DMLP approaches its Q1 2026 earnings report today against a backdrop of steady price weakness — down 7% over the past month to $26.10, with a 3% drop in the final session alone. Yet the positioning data tells a notably calm story.
Short sellers are not leaning in. Short interest is just 1.1% of the free float, and the trend is gently lower — down about 5% over the past month. Borrow conditions are loose. Cost to borrow runs at roughly 2%, less than half what it was in late March when it briefly touched nearly 7%. Availability remains ample, with well over three-quarters of the lending pool still untapped. With a days-to-cover reading of under 1.5 sessions, there is no squeeze dynamic in sight. Options positioning is also measured — the put/call ratio is at 0.67, essentially in line with its 20-day average, z-score a modest 0.56. Neither the derivatives market nor the lending market shows unusual anxiety heading into the print.
The more interesting angle is the affiliated-entity buying that ran through February. Dorchester Minerals Operating LP — an affiliated company — purchased roughly 20,000 units in three tranches across February 11–13, paying between $25.08 and $25.29. That cluster of buying came at prices very close to the current level, suggesting the affiliated entity viewed the mid-$25s as attractive. Net insider activity over the 90-day window totals approximately 125,000 shares valued near $2.8 million — a meaningful accumulation for a partnership of this size. The contrast with the CEO and CFO's small December sales (routine in scale, partially offset by a same-day award) reinforces the picture of entity-level conviction rather than executive trimming. Morgan Stanley also added nearly 348,000 units in the December quarter, a notable build for a holder at that level.
Peers have held up better on the week. EOG gained 3.7% over the same five-day stretch and CHRD added 6.4%, while DMLP fell nearly 7%. KRP and TXO each managed modest gains. The gap suggests DMLP's retreat has been at least partially idiosyncratic. The RSI14 has slipped to 38.9 — approaching, but not yet at, oversold territory — which adds context to the recent drift without indicating a capitulation.
Past earnings reactions have been mixed: the February 2026 print produced a 6% one-day gain and held most of those gains over five days, while the November 2025 event saw the stock give back 1.7% on the day and slide 5.5% over the following week. Today's report will therefore test whether the affiliated buying near current levels reflects genuine confidence in the distribution outlook — or whether softer energy prices have pressured the royalty income that drives Dorchester's distributions harder than the market has yet priced in.
See the live data behind this article on ORTEX.
Open DMLP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
